New Studies

New studies reveal significant medical progression for mesothelioma patients of all stages. Know which treatments are working best and which aren’t.

Europe | International | New Drugs | New Studies | Research | Treatments | Updates

Mesothelioma Patients May Need Medication to Reduce Clot Risk
ByAlex Strauss December 20, 2014May 27, 2019

Researchers in Ankara, Turkey have just released a new study on the increased risk of thromboembolic events (TEEs) in patients…

Read More Mesothelioma Patients May Need Medication to Reduce Clot Risk
Asbestos | New Drugs | New Studies | Research | Treatments | Updates

Newly Approved Drug for Asbestosis-like Condition Now Being Tested for Mesothelioma
ByAlex Strauss December 2, 2014March 16, 2017

Following the recent FDA approval of a new drug for a form of lung scarring, researchers have begun testing the…

Read More Newly Approved Drug for Asbestosis-like Condition Now Being Tested for Mesothelioma
Asia | International | Mesothelioma | New Drugs | New Studies | Research | Treatments | Updates

Japanese Doctors Test Potential New Target for Mesothelioma Therapy
ByAlex Strauss November 28, 2014March 24, 2019

. Mesothelioma is a fast-growing and currently incurable cancer that occurs most often in people who have been exposed to…

Read More Japanese Doctors Test Potential New Target for Mesothelioma Therapy
New Drugs | New Studies | Research | Treatments | Updates

‘Tunnels’ Between Cells: A New Target for Mesothelioma Treatment?
ByAlex Strauss November 19, 2014July 9, 2019

Doctors with Memorial Sloan Kettering Cancer Center in New York and the University of Minnesota in Minneapolis have just released…

Read More ‘Tunnels’ Between Cells: A New Target for Mesothelioma Treatment?
Asia | International | Mesothelioma | Multi-Modality Therapy | New Studies | Research | Treatments | Updates

Promising Mesothelioma Therapy Combo Reportedly Shrinks Tumors, Inhibits Regrowth
ByAlex Strauss November 13, 2014March 16, 2017

Doctors in Japan are optimistic about a new treatment protocol that they say shrunk mesothelioma tumors in mice by 80%…

Read More Promising Mesothelioma Therapy Combo Reportedly Shrinks Tumors, Inhibits Regrowth
Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments | Updates

Oral Drug Combination May Prolong Survival in Previously-Treated Mesothelioma Patients
ByAlex Strauss November 7, 2014March 16, 2017

Doctors in one of the world’s top mesothelioma hotspots say they have found an oral drug combination that appears to…

Read More Oral Drug Combination May Prolong Survival in Previously-Treated Mesothelioma Patients
Chemotherapy | New Drugs | New Studies | Research | Treatments | Updates

Vegetable Compound May Help Treat Mesothelioma with Fewer Side Effects
ByAlex Strauss November 3, 2014July 9, 2019

Phenethyl isothiocyanate (PEITC) is a naturally occurring isothiocyanate. Brussels sprouts, watercress, radishes and capers all get their characteristic flavors from…

Read More Vegetable Compound May Help Treat Mesothelioma with Fewer Side Effects
Biopsy | Diagnosis | New Studies | Prognosis | Research | Updates

Mesothelioma Subtype Predicts Poor Survival Odds
ByAlex Strauss October 29, 2014March 25, 2019

Histological subtyping, which involves classifying mesothelioma types by certain microscopic features, plays a crucial role in diagnosis, treatment, and determining…

Read More Mesothelioma Subtype Predicts Poor Survival Odds
Asia | Chemotherapy | International | Mesothelioma | New Studies | Research | Treatments | Updates

Alimta May Extend Mesothelioma Survival as a Maintenance Therapy
ByAlex Strauss October 23, 2014March 20, 2019

T Scientists in Japan have just published details of a case they say could be pivotal to the treatment of…

Read More Alimta May Extend Mesothelioma Survival as a Maintenance Therapy
Chemotherapy | New Drugs | New Studies | Research | Treatments | Updates

Orphan Drug Improves Mesothelioma Survival in Phase II Trial
ByAlex Strauss October 7, 2014July 7, 2019

T. Researchers with the National Cancer Institute report that, when administered along with the traditional chemotherapy, amatuximab appears to be…

Read More Orphan Drug Improves Mesothelioma Survival in Phase II Trial

1 (888) 378-1331

New Studies

Mesothelioma Patients May Need Medication to Reduce Clot Risk

Newly Approved Drug for Asbestosis-like Condition Now Being Tested for Mesothelioma

Japanese Doctors Test Potential New Target for Mesothelioma Therapy

‘Tunnels’ Between Cells: A New Target for Mesothelioma Treatment?

Promising Mesothelioma Therapy Combo Reportedly Shrinks Tumors, Inhibits Regrowth

Oral Drug Combination May Prolong Survival in Previously-Treated Mesothelioma Patients

Vegetable Compound May Help Treat Mesothelioma with Fewer Side Effects

Mesothelioma Subtype Predicts Poor Survival Odds

Alimta May Extend Mesothelioma Survival as a Maintenance Therapy

Orphan Drug Improves Mesothelioma Survival in Phase II Trial

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES